Soaring Toward a $100 Billion Bio-Manufacturing Hub in India

India is the third-largest biotechnology destination in the Asia Pacific and one of the top 12 biotechnology locations worldwide. India's biotechnology sector reached US$80.12 billion in 2022, up 14% from the previous year. In the last 10 years, the value of the Indian economy has multiplied, and COVID-19 has given the sector a much-needed boost.

Soaring Toward a $100 Billion Bio-Manufacturing Hub in India

As one of the top locations for bio innovation and biomanufacturing today, India is recognized as a rising sector and a crucial component of its goal of having a US$5 trillion economy by 2024. The biotechnology industry in India is divided into biopharmaceuticals, agriculture, bio information technology, and services.

Bio Pharmaceuticals:

India is one of the world's largest exporters of affordable pharmaceuticals and vaccinations. With the most licensed biosimilars on the domestic market, India is also a global leader in this field.

Bio agriculture:

With nearly 55% of Indian terrain under agriculture and allied activities, India is one of the largest producers of Bt-Cotton and has the 5th Largest Area of Organic Agriculture Land Globally.

BioIndustrial:

The application of biotechnology in industrial processes is changing how garbage is disposed of and how goods are manufactured across the nation.

BioIT & Services:

India offers a strong capability in contract manufacturing, research, and clinical trials, and is home to the most US FDA-approved plants globally outside of the US